Amy Kruse

Dr. Amy Kruse is the General Partner and Chief Investment Officer of Satori Neuro, a stage-agnostic fund focused on neurotechnology. Amy leverages her decades of experience as a neuroscientist, her prior roles as an operator and a government program manager, and her network to discover transformational companies addressing the largest mental health, brain health, and wellness challenges and opportunities. Prior to leading Satori Neuro, Amy was General Partner at Prime Movers Lab, CTO of Cubic Global Defense, Chief Science Officer at Optios, and served as a government civilian program manager at the Defense Advanced Research Projects Agency (DARPA), where she created and oversaw the Agency’s first performance-oriented neuroscience programs.